EUVIMEDEUVIMED entdecken
Crossref

Hyperhomocysteinemia and MTHFR C677T polymorphism in SARS-CoV-2 infection severity

Anurag Mishra

Global Translational Medicine · 12.05.2026 · 5 (2) · 025320059

DOI: 10.36922/gtm025320059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Global Translational Medicine, online erschienen am 12.05.2026. Verfasst von Anurag Mishra.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

COVID-19 virus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) has imposed a huge burden of mortality, morbidity, and socio-economic issues worldwide. Dominating transmission efficacy and the surge in instant genetic mutations pose challenges to the overwhelmed healthcare system. In this study, we aim to explore the role of homocysteine (Hcy) as a biomarker in COVID-19 and to develop strategies to mitigate the severity of SARS-CoV-2 infection. We reviewed the biochemical, physiological, and genetic implications of COVID-19. Upon SARS-CoV-2 exposure, Hcy metabolism is disrupted, leading to hyperhomocysteinemia (HHcy) and inducing inflammatory markers, e.g., interleukins (IL-6 and IL-7), tumor necrosis factor, interferon-γ, and C-reactive protein, which are characterized as a cytokine storm. HHcy develops numerous complications, including cardiovascular disorders, neural problems, and musculoskeletal disorders. However, nutritional deficiencies, e.g., folic acid, vitamin B6, and vitamin B12, and elevated serum creatinine are the important determinants of Hcy concentrations in the body. Additionally, the MTHFR C677T polymorphism is also a key factor that modulates Hcy levels and increases the risk of viral incidence. Overall, the identification of biochemical, metabolic, and genetic biomarkers may improve risk stratification, inform COVID-19 management, and help identify potential therapeutic targets.

Zitieren

APA

Mishra, A. (2026). Hyperhomocysteinemia and MTHFR C677T polymorphism in SARS-CoV-2 infection severity. Global Translational Medicine, 5(2), 025320059. https://doi.org/10.36922/gtm025320059

Vancouver

Mishra A. Hyperhomocysteinemia and MTHFR C677T polymorphism in SARS-CoV-2 infection severity. Global Translational Medicine. 2026;5(2):025320059. doi:10.36922/gtm025320059

BibTeX
@article{Mishra2026,
  author = {Mishra, Anurag},
  title = {Hyperhomocysteinemia and MTHFR C677T polymorphism in SARS-CoV-2 infection severity},
  journal = {Global Translational Medicine},
  year = {2026},
  volume = {5},
  number = {2},
  pages = {025320059},
  doi = {10.36922/gtm025320059}
}
Kostenlos starten →